The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide
about
Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cellsStructure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor geneVPAC receptors: structure, molecular pharmacology and interaction with accessory proteinsNeuropeptide regulation of signaling and behavior in the BNST.Structure of the human VIPR2 gene for vasoactive intestinal peptide receptor type 2Expression and distribution of vasoactive intestinal polypeptide receptor VPAC(2) mRNA in human airwaysTransgenic approach reveals expression of the VPAC2 receptor in phenotypically defined neurons in the mouse suprachiasmatic nucleus and in its efferent target sitesExpression of pituitary adenylate cyclase-activating polypeptide 1 and 2 receptor mRNA in gallbladder tissue of patients with gallstone or gallbladder polypsMutations in the second cytoplasmic loop of the rat parathyroid hormone (PTH)/PTH-related protein receptor result in selective loss of PTH-stimulated phospholipase C activityAgnathan VIP, PACAP and their receptors: ancestral origins of today's highly diversified formsRoles for pituitary adenylate cyclase-activating peptide (PACAP) expression and signaling in the bed nucleus of the stria terminalis (BNST) in mediating the behavioral consequences of chronic stress.Pituitary adenylate cyclase activating peptide (PACAP) in the enteropancreatic innervation.Pituitary adenylate cyclase-activating polypeptide activates K(ATP) current in rat atrial myocytes.Molecular cloning of the helodermin and exendin-4 cDNAs in the lizard. Relationship to vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide and glucagon-like peptide 1 and evidence against the existence of mammalian hNovel alternatively spliced exon in the extracellular ligand-binding domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor (PAC1R) selectively increases ligand affinity and alters signal transduction coupling durinSelect cognitive deficits in vasoactive intestinal peptide deficient mice.The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation.Neuropeptides and the puzzle of bone remodeling. State of the art.Mechanisms of pituitary adenylate cyclase activating polypeptide (PACAP)-induced depolarization of sympathetic superior cervical ganglion (SCG) neurons.Pituitary adenylate cyclase-activating polypeptide (PACAP)/PAC1HOP1 receptor activation coordinates multiple neurotrophic signaling pathways: Akt activation through phosphatidylinositol 3-kinase gamma and vesicle endocytosis for neuronal survivalVIP neuroprotection against excitotoxic lesions of the developing mouse brain.Pituitary adenylate cyclase-activating polypeptide stimulates glucose production via the hepatic sympathetic innervation in rats.Is bone a target-tissue for the nervous system? New advances on the understanding of their interactionsPACAP is present in the olfactory system and evokes calcium transients in olfactory receptor neurons.Pituitary adenylate cyclase-activating polypeptide and its receptors in amphibians.Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C.Importance of conserved cysteines in the extracellular loops of human PACAP/VIP1 receptor for ligand binding and stimulation of cAMP production.Vasoactive intestinal peptide and the mammalian circadian system.Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP.Effect of vasoactive intestinal peptide (VIP)-related peptides on cholinergic neurogenic and direct mucus secretion in ferret trachea in vitro.PAC1hop, null and hip receptors mediate differential signaling through cyclic AMP and calcium leading to splice variant-specific gene induction in neural cellsTargeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in miceCharacterisation of the mouse vasoactive intestinal peptide receptor type 2 gene, Vipr2, and identification of a polymorphic LINE-1-like sequence that confers altered promoter activity.STC1 induction by PACAP is mediated through cAMP and ERK1/2 but not PKA in cultured cortical neuronsPituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomasPituitary adenylate cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells.Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.PYK-2 is tyrosine phosphorylated after activation of pituitary adenylate cyclase activating polypeptide receptors in lung cancer cells.Pituitary adenylate cyclase-activating polypeptide induces postsynaptically expressed potentiation in the intra-amygdala circuit
P2860
Q24563905-3CEE1C96-747A-4E2D-984B-7F742E6080D0Q24564119-720443D1-A39E-4347-8C0E-DAF1651BFEA2Q26827172-5C9C7566-1F83-4AE0-9806-D277165243D9Q26866326-A98A2FB3-0263-4EF9-8568-960B25081F8DQ28144174-4B802A0F-2A80-4F1A-8E60-5367F6940F9EQ28188683-6D433BA3-30B5-4342-AE6F-5C7B9F42E67BQ28256945-50F7992E-5958-42E6-8433-8FB7A7E229C6Q28303203-5AA1269A-BE35-4B2B-9B9B-FA76B2D244B0Q28572877-19316BE1-D540-4230-A8C1-ADB0A3B48A0EQ28728067-16A1F0FD-B38E-4B96-B1B5-E0DD546A7C83Q30473327-4A893D33-8F19-40E1-83B2-574CC52B8A45Q31808297-31FC1ACC-AA0F-430C-BC53-DE0C30018DD1Q31939897-0082AAAF-4B66-4477-B932-3C2A4564F536Q32067761-48C6A9A2-3E4F-4F10-A6E0-BF04E602A846Q33181839-9DD4BE85-F2FD-4048-A93C-4A2EDA27ED42Q33350694-839E0825-D5A2-4AAF-9BDD-BD91EB81DB3EQ33360305-D6C77B92-87CB-45D5-87A8-4D12D2768037Q33368019-086F41B3-DD29-451A-B3DD-C7969F2157BAQ33369005-4EEF839C-AFCB-40F5-9F47-D7549F874227Q33744662-AD2A5806-CC74-4EDF-8C9F-F83ED19539E4Q33838449-4577D578-9DDA-48A9-89F8-8B579A53D49CQ33930193-C7CA48D7-E46E-4567-9935-3C87DB0BA7FDQ33997030-909180D5-F644-4D54-9084-CB69005549B4Q34291476-B91B88C8-7D4B-4B62-B98E-87CEF8120C82Q34310714-9C1F5BD5-FBEE-4A1A-BC67-3A6CBCC21BF7Q34384700-25DA4551-310F-4E03-83CE-A482BE0E6EC7Q34490466-AC9E610B-7353-48B0-B341-3F60C287200BQ34638010-6CBBD028-0F4B-4AAE-B09F-6FB97C96C342Q34789781-C761CB2A-7EEB-4E8D-8D9F-AC274003641DQ35041715-06099E8A-721C-408A-8FEA-027E72B05A17Q35184653-8B2E024F-F439-48B1-9B53-156CCA18DDDEQ35295564-8EC85F7F-72CB-4E31-9FEA-6F04B989008AQ35370039-7218B12D-0287-4255-B2D6-AE218B8C8AB9Q35648983-3D7755FE-08D9-4694-88DB-33B6A2B5EFE0Q35667237-91F56A77-1601-4EBE-BEAC-31F5D167DF5BQ35786043-E4806BD5-D569-4AB3-A18A-03311491D99EQ36085551-753C682A-1B1F-4F23-9F88-4A747AB00355Q36153216-F13A9960-FF1B-4066-9DA9-67197D371E2BQ36166344-F3F50E7C-97B4-4E53-B07F-9E71B4D5BD78Q36374909-EB938E1E-93DD-49E7-9E54-EAE18A871ADF
P2860
The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide
description
1993 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1993
@ast
im November 1993 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1993/11/08)
@sk
vědecký článek publikovaný v roce 1993
@cs
wetenschappelijk artikel (gepubliceerd op 1993/11/08)
@nl
наукова стаття, опублікована в листопаді 1993
@uk
مقالة علمية (نشرت في 8-11-1993)
@ar
name
The VIP2 receptor: molecular c ...... vasoactive intestinal peptide
@ast
The VIP2 receptor: molecular c ...... vasoactive intestinal peptide
@en
The VIP2 receptor: molecular c ...... vasoactive intestinal peptide
@nl
type
label
The VIP2 receptor: molecular c ...... vasoactive intestinal peptide
@ast
The VIP2 receptor: molecular c ...... vasoactive intestinal peptide
@en
The VIP2 receptor: molecular c ...... vasoactive intestinal peptide
@nl
prefLabel
The VIP2 receptor: molecular c ...... vasoactive intestinal peptide
@ast
The VIP2 receptor: molecular c ...... vasoactive intestinal peptide
@en
The VIP2 receptor: molecular c ...... vasoactive intestinal peptide
@nl
P2093
P1433
P1476
The VIP2 receptor: molecular c ...... vasoactive intestinal peptide
@en
P2093
A. J. Harmar
E. M. Lutz
J. A. Morrow
K. M. West
W. J. Sheward
P356
10.1016/0014-5793(93)81668-P
P407
P577
1993-11-08T00:00:00Z